SIGN UP
LOG IN
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·06/23/2025 12:08:57
Listen to the news
Gainers
- Indaptus Therapeutics (NASDAQ:INDP) stock increased by 141.3% to $0.65 during Monday's pre-market session. The market value of their outstanding shares is at $4.3 million.
- Impact BioMedical (AMEX:IBO) shares moved upwards by 104.55% to $0.74. The company's market cap stands at $4.3 million.
- Cidara Therapeutics (NASDAQ:CDTX) shares moved upwards by 66.84% to $35.07. The company's market cap stands at $272.6 million.
- Forte Biosciences (NASDAQ:FBRX) stock moved upwards by 40.78% to $20.64. The company's market cap stands at $96.5 million.
- CARISMA Therapeutics (NASDAQ:CARM) shares moved upwards by 33.18% to $0.59. The market value of their outstanding shares is at $18.4 million.
- Exelixis (NASDAQ:EXEL) stock increased by 23.13% to $49.71. The market value of their outstanding shares is at $11.0 billion.
Losers
- Compass Pathways (NASDAQ:CMPS) shares declined by 35.2% to $3.0 during Monday's pre-market session. The company's market cap stands at $433.1 million.
- SS Innovations (NASDAQ:SSII) shares declined by 21.39% to $5.44. The company's market cap stands at $1.3 billion.
- Alaunos Therapeutics (NASDAQ:TCRT) shares decreased by 18.19% to $3.51. The market value of their outstanding shares is at $7.0 million.
- Hims & Hers Health (NYSE:HIMS) shares fell 17.13% to $53.22. The market value of their outstanding shares is at $14.3 billion.
- Processa Pharmaceuticals (NASDAQ:PCSA) shares fell 15.13% to $0.27. The company's market cap stands at $3.8 million.
- Innovative Eyewear (NASDAQ:LUCY) shares decreased by 13.32% to $3.06. The market value of their outstanding shares is at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.